Prostate News Archive
06-Nov-2007
(AFX UK Focus) 2007-11-05 12:20 GMT: Novacea halts Phase III trial of prostate cancer drug on imbalance of deaths (Interactive Investor)
NEW YORK (Thomson Financial) - Novacea Inc. Monday said it had halted the Phase III clinical trial of its drug Asentar, an investigational prostate cancer therapy. Archbishop Gregory Undergoes Surgery for Prostate Cancer (FOX 5 Atlanta)
ATLANTA (AP) -- Atlanta Archbishop Wilton Gregory has undergone surgery for prostate cancer but a church spokeswoman declined to comment on his condition at his request. (AFX UK Focus) 2007-11-05 13:09 GMT: Medivation says MDV3100 trial shows reduced levels for prostate cancer antingen (Interactive Investor)
BOSTON (Thomson Financial) - Medivation Inc. Monday said its selective androgen receptor modulator, MDV3100, showed substantial reductions in serum levels of prostate specific antigen in six patients in a phase 1-2 trial. Novacea ends late-stage trial of prostate cancer drug (Reuters via Yahoo! News)
Drugmaker Novacea Inc ended a late-stage trial of its prostate cancer drug Asentar, after a treatment arm containing the drug showed a higher death rate compared with the standard care, driving shares down more than 69 percent to a lifetime low. Radiation Seed Treatment Helps Younger Men Fight Prostate Cancer (MedicineNet.com)
Title: Radiation Seed Treatment Helps Younger Men Fight prostate Cancer Category: Health News Created: 11/3/2007 2:00:00 AM Last Editorial Review: 11/5/2007
Back to Prostate News Archive
